Start an analysis for CRMD
CorMedix Inc.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $75m | 30-Sep-26 | 10-Q filed 13-Aug-26 |
| Remaining authorization | $58m | 30-Sep-26 | 10-Q filed 13-Aug-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $6m | 30-Jun-26 | 10-Q filed 13-Aug-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 02-Feb-26 | $75m | $58m | n/a | Board of Directors approved a share repurchase program to repurchase up to $75 million of CorMedix outstanding common stock. Repurchases may be made from time to time in privately negotiated transactions, through block trades, pursuant to open market purchases or pursuant to trading plans. The share repurchase program does not require the Company to acquire any amount of shares, and may be…10-Q filed 13-Aug-26 |
Open-market repurchases
- Apr ’26
- May ’26
- Jun ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Jun-26 | 0 | — | $0 | 10-Q filed 13-Aug-26 |
| 31-May-26 | 814,281 | $7.85 | $6m | 10-Q filed 13-Aug-26 |
| 30-Apr-26 | 0 | — | $0 | 10-Q filed 13-Aug-26 |